547 related articles for article (PubMed ID: 33777771)
1. Identification of a Novel Four-Gene Signature Correlated With the Prognosis of Patients With Hepatocellular Carcinoma: A Comprehensive Analysis.
Zhu W; Ru L; Ma Z
Front Oncol; 2021; 11():626654. PubMed ID: 33777771
[TBL] [Abstract][Full Text] [Related]
2. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
[TBL] [Abstract][Full Text] [Related]
3. An Inflammatory Response-Related Gene Signature Can Impact the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma.
Lin Z; Xu Q; Miao D; Yu F
Front Oncol; 2021; 11():644416. PubMed ID: 33828988
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.
Wang Y; Song F; Zhang X; Yang C
Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359
[TBL] [Abstract][Full Text] [Related]
5. Identification of an Endoplasmic Reticulum Stress-Related Gene Signature to Evaluate the Immune Status and Predict the Prognosis of Hepatocellular Carcinoma.
Song D; Zhou Z; Zhang D; Wu J; Hao Q; Zhao L; Ren H; Zhang B
Front Genet; 2022; 13():850200. PubMed ID: 35711939
[TBL] [Abstract][Full Text] [Related]
6. Identification and Validation of Ubiquitin-Specific Proteases as a Novel Prognostic Signature for Hepatocellular Carcinoma.
Ni W; Bian S; Zhu M; Song Q; Zhang J; Xiao M; Zheng W
Front Oncol; 2021; 11():629327. PubMed ID: 33718205
[TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of a Novel Six-Gene Expression Signature for Predicting Hepatocellular Carcinoma Prognosis.
Yan Z; He M; He L; Wei L; Zhang Y
Front Immunol; 2021; 12():723271. PubMed ID: 34925311
[TBL] [Abstract][Full Text] [Related]
8. A novel cuproptosis-related prognostic gene signature and validation of differential expression in hepatocellular carcinoma.
Li Y; Zeng X
Front Pharmacol; 2022; 13():1081952. PubMed ID: 36703728
[No Abstract] [Full Text] [Related]
9. A novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma.
Yang Y; Ye X; Zhang H; Lin Z; Fang M; Wang J; Yu Y; Hua X; Huang H; Xu W; Liu L; Lin Z
Front Genet; 2022; 13():1068837. PubMed ID: 36685838
[No Abstract] [Full Text] [Related]
10. Comprehensive analysis to identify the neurotransmitter receptor-related genes as prognostic and therapeutic biomarkers in hepatocellular carcinoma.
Wang X; Li Y; Shi Y; Luo J; Zhang Y; Pan Z; Wu F; Tian J; Yu W
Front Cell Dev Biol; 2022; 10():887076. PubMed ID: 35990607
[No Abstract] [Full Text] [Related]
11. Identifying a Hypoxia-Related Long Non-Coding RNAs Signature to Improve the Prediction of Prognosis and Immunotherapy Response in Hepatocellular Carcinoma.
Tang P; Qu W; Wang T; Liu M; Wu D; Tan L; Zhou H
Front Genet; 2021; 12():785185. PubMed ID: 34917132
[No Abstract] [Full Text] [Related]
12. Construction and validation of a pyroptosis-related gene signature in hepatocellular carcinoma based on RNA sequencing.
He J; Ran J; Li J; Chen D
Transl Cancer Res; 2022 Jun; 11(6):1510-1522. PubMed ID: 35836524
[TBL] [Abstract][Full Text] [Related]
13. A Novel Oxidative Phosphorylation-Associated Gene Signature for Prognosis Prediction in Patients with Hepatocellular Carcinoma.
Chen W; Yang Z; Chen Y
Dis Markers; 2022; 2022():3594901. PubMed ID: 36105252
[TBL] [Abstract][Full Text] [Related]
14. Prognostic signature for hepatocellular carcinoma based on 4 pyroptosis-related genes.
Duan S; Gao J; Lou W; Zhang Y; Deng Y; Wang C; Huang H; Xu H; Guo S; Lai S; Xi F; Li Z; Deng L; Zhong Y
BMC Med Genomics; 2022 Jul; 15(1):166. PubMed ID: 35902905
[TBL] [Abstract][Full Text] [Related]
15. A novel prognostic signature based on four glycolysis-related genes predicts survival and clinical risk of hepatocellular carcinoma.
Chen Z; Zou Y; Zhang Y; Chen Z; Wu F; Shi N; Jin H
J Clin Lab Anal; 2021 Nov; 35(11):e24005. PubMed ID: 34523732
[TBL] [Abstract][Full Text] [Related]
16. Identification of Potential Hub Genes Related to Diagnosis and Prognosis of Hepatitis B Virus-Related Hepatocellular Carcinoma via Integrated Bioinformatics Analysis.
Tang Y; Zhang Y; Hu X
Biomed Res Int; 2020; 2020():4251761. PubMed ID: 33376723
[TBL] [Abstract][Full Text] [Related]
17. Ferroptosis-Related Hub Genes in Hepatocellular Carcinoma: Prognostic Signature, Immune-Related, and Drug Resistance Analysis.
Wang W; Pan F; Lin X; Yuan J; Tao C; Wang R
Front Genet; 2022; 13():907331. PubMed ID: 35938001
[No Abstract] [Full Text] [Related]
18. Identification and characterization of a 25-lncRNA prognostic signature for early recurrence in hepatocellular carcinoma.
Fu Y; Wei X; Han Q; Le J; Ma Y; Lin X; Xu Y; Liu N; Wang X; Kong X; Gu J; Tong Y; Wu H
BMC Cancer; 2021 Oct; 21(1):1165. PubMed ID: 34717566
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive
Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
Front Immunol; 2022; 13():931906. PubMed ID: 35958598
[TBL] [Abstract][Full Text] [Related]
20. A Novel Ferroptosis-related Gene Signature for Overall Survival Prediction in Patients with Hepatocellular Carcinoma.
Liang JY; Wang DS; Lin HC; Chen XX; Yang H; Zheng Y; Li YH
Int J Biol Sci; 2020; 16(13):2430-2441. PubMed ID: 32760210
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
